Innocan Pharma Corporation (CSE:INNO) CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the two have signed a manufacturing and distribution agreement.
Bincovich says Endless Sky will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its Health Canada-licensed facility in Redvers, Saskatchewan.
In exchange, ESI will pay Innocan Israel a fee per product in addition to royalties based on net sales.
Price: 1.42 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Industry & services
Emmaus Life Sciences Inc CEO Yutaka Niihara joined Proactive to discuss the Torrance, California-based group's focus on expanding its FDA approved drug, Endari, to treat sickle cell disease internationally, specifically focusing in on the Middle East. Niihara says recently, the National...
Industry & services
PyroGenesis Canada says it has received a $6M plasma torch order...
Retail & consumer
Prev article
